AU7466900A - A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 - Google Patents
A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2Info
- Publication number
- AU7466900A AU7466900A AU74669/00A AU7466900A AU7466900A AU 7466900 A AU7466900 A AU 7466900A AU 74669/00 A AU74669/00 A AU 74669/00A AU 7466900 A AU7466900 A AU 7466900A AU 7466900 A AU7466900 A AU 7466900A
- Authority
- AU
- Australia
- Prior art keywords
- phe
- tyr
- ala
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1027—Tetrapeptides containing heteroatoms different from O, S, or N
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9903291A SE9903291D0 (en) | 1999-09-15 | 1999-09-15 | New process |
SE9903291 | 1999-09-15 | ||
PCT/SE2000/001747 WO2001019849A1 (en) | 1999-09-15 | 2000-09-07 | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh¿2? |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7466900A true AU7466900A (en) | 2001-04-17 |
Family
ID=20416994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU74669/00A Abandoned AU7466900A (en) | 1999-09-15 | 2000-09-07 | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1212350A1 (en) |
JP (1) | JP2003509437A (en) |
AU (1) | AU7466900A (en) |
CA (1) | CA2383184A1 (en) |
SE (1) | SE9903291D0 (en) |
WO (1) | WO2001019849A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
RU2543350C2 (en) | 2003-01-28 | 2015-02-27 | Айронвуд Фармасьютикалз, Инк. | Methods and compositions for treating gastrointestinal disorders |
JP4540568B2 (en) * | 2005-07-26 | 2010-09-08 | 株式会社トクヤマ | Method for producing L-carnosine |
EA020466B1 (en) | 2007-06-04 | 2014-11-28 | Синерджи Фармасьютикалз Инк. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
FR2928372B1 (en) * | 2008-03-10 | 2010-12-31 | Solvay | PEPTIDE SYNTHESIS METHOD |
EP2810951B1 (en) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
ES2624828T3 (en) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Guanylate cyclase agonists useful for the treatment of gastrointestinal disorders, inflammation, cancer and others |
ES2608050T3 (en) | 2008-12-03 | 2017-04-05 | Synergy Pharmaceuticals Inc. | Guanylate cyclase C agonist formulations and methods of use |
CN103819403B (en) | 2008-12-31 | 2017-01-04 | 阿德利克斯公司 | For treating the disease relevant with fluid retention or salt over loading and the Compounds and methods for of disorder of gastrointestinal tract |
WO2018129556A1 (en) | 2017-01-09 | 2018-07-12 | Ardelyx, Inc. | Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
EA201391254A1 (en) | 2011-03-01 | 2014-02-28 | Синерджи Фармасьютикалз Инк. | METHOD FOR OBTAINING GUANYLATZCLAZE AGONISTS C |
AU2013304812B2 (en) | 2012-08-21 | 2016-06-09 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
US10376481B2 (en) | 2012-08-21 | 2019-08-13 | Ardelyx, Inc. | Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders |
CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
CA2905435A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
KR20230132619A (en) | 2013-04-12 | 2023-09-15 | 알데릭스, 인코포레이티드 | Nhe3-binding compounds and methods for inhibiting phosphate transport |
PT3004138T (en) | 2013-06-05 | 2024-06-18 | Bausch Health Ireland Ltd | Ultra-pure agonists of guanylate cyclase c, method of making and using same |
AU2018205400B2 (en) | 2017-01-09 | 2022-07-14 | Ardelyx, Inc. | Compounds useful for treating gastrointestinal tract disorders |
EP3565811A1 (en) | 2017-01-09 | 2019-11-13 | Ardelyx, Inc. | Inhibitors of nhe-mediated antiport |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2567524B1 (en) * | 1984-07-10 | 1987-11-27 | Sanofi Sa | PROCESS FOR THE SYNTHESIS OF SOMATOCRININ IN LIQUID PHASE AND INTERMEDIATE PEPTIDES |
GB9516994D0 (en) * | 1995-08-18 | 1995-10-18 | Iaf Biochem Int | Solution synthesis of peripheral acting analgestic opioid tetrapeptides |
SE9800865D0 (en) * | 1998-03-16 | 1998-03-16 | Astra Ab | New Process |
-
1999
- 1999-09-15 SE SE9903291A patent/SE9903291D0/en unknown
-
2000
- 2000-09-07 CA CA002383184A patent/CA2383184A1/en not_active Abandoned
- 2000-09-07 EP EP00963222A patent/EP1212350A1/en not_active Withdrawn
- 2000-09-07 WO PCT/SE2000/001747 patent/WO2001019849A1/en not_active Application Discontinuation
- 2000-09-07 JP JP2001523626A patent/JP2003509437A/en active Pending
- 2000-09-07 AU AU74669/00A patent/AU7466900A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2383184A1 (en) | 2001-03-22 |
JP2003509437A (en) | 2003-03-11 |
EP1212350A1 (en) | 2002-06-12 |
SE9903291D0 (en) | 1999-09-15 |
WO2001019849A1 (en) | 2001-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7466900A (en) | A process for the preparation of h-tyr-d-ala-phe(f)-phe-nh2 | |
AU3994299A (en) | Process for preparing 4-aminodiphenylamines | |
AU7902400A (en) | Method for the preparation of 5-carboxyphthalide | |
AU3826799A (en) | Process for the preparation of styrenes | |
AU2001273762A1 (en) | Process for the preparation of (r)-2-alkyl-3-phenyl-1-propanols | |
AU1538901A (en) | Polymersation process | |
AU7972200A (en) | Process for the preparation of urea | |
AU2466700A (en) | Process for the preparation of urea | |
AU1434301A (en) | Process for the preparation of sulfamides | |
AU5831500A (en) | Process for the preparation of polyols | |
AU2926399A (en) | Process for the preparation of styrenes | |
AU2943400A (en) | Process for the preparation of alpha-aminoketone derivatives | |
AU2002229648A1 (en) | A process for the preparation of citalopram | |
AU7306100A (en) | A stereoselective process for the preparation of endo-3-aminoazabicycloalkanes | |
AU2829700A (en) | Processes for the preparation of alpha-aminoketones | |
AU2002310898A1 (en) | Process for the preparation of a polymer-amine | |
AU6870600A (en) | Process for the preparation of 2,3-dihydroazepine compounds | |
AU1130901A (en) | Method for the preparation of 5-carboxyphthalide | |
AU5779998A (en) | Process for the preparation of cyanoarylmethylamine | |
AU6832098A (en) | A process for the preparation of tetraazamacrocycles | |
AU5462901A (en) | Process for the preparation of (pyridinylidene)-phthalides | |
AU2820700A (en) | Process for the preparation of cefuroxime | |
AU3840199A (en) | Process for the preparation of a pharmaceutical intermediate | |
AU1388901A (en) | Process for the production of trifluoromethylacetophenones | |
AU5550700A (en) | Novel process |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |